SCHEMBL7959988

SCHEMBL7959988

COc1cc(C(O)C2CCCCC2=O)ccc1C

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.52
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP2D6 P10635 1/20 0.37
PDE4B Q07343 4/20 0.37
PDE4A P27815 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485806 0.80 ALDH1A1 (0.55) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL14292323 0.80 ALDH1A1 (0.55) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL13254545 0.80 ALDH1A1 (0.55) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL8065500 0.78 MAPT (0.56) MAPTALDH1A1POLBL3MBTL1MAPK1
SCHEMBL8056693 0.78 MAPT (0.56) MAPTALDH1A1POLBL3MBTL1MAPK1
SCHEMBL7959844 0.77 MAPK1 (0.45) MAPTALDH1A1USP2LMNAPOLB
SCHEMBL7483180 0.77 MAPT (0.55) MAPTALDH1A1POLBL3MBTL1MAPK1
SCHEMBL7490400 0.77 MAPT (0.55) MAPTALDH1A1POLBL3MBTL1MAPK1
SCHEMBL7960098 0.76 MAPT (0.47) MAPTALDH1A1USP2LMNAPOLB
SCHEMBL7961084 0.75 MAPT (0.47) MAPTALDH1A1USP2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed